Share on LinkedInShare on LinkedIn

ARTICLE · 11 DECEMBER 2025

Litigating The Fix In Merger Cases: Some Lessons And Continuing Questions Following FTC v. GTCR

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

On November 10, Judge Jeffrey Cummings of the Northern District of Illinois denied the Federal Trade Commission's (FTC) request for a preliminary injunction to prohibit the closing of GTCR's acquisition of Surmodics, giving GTCR control over the two largest suppliers of hydrophilic coatings for medical devices like catheters and surgical guidewires.

United StatesAntitrust/Competition Law

On November 10, Judge Jeffrey Cummings of the Northern District of Illinois denied the Federal Trade Commission's (FTC) request for a preliminary injunction to prohibit the closing of GTCR's acquisition of Surmodics, giving GTCR control over the two largest suppliers of hydrophilic coatings for medical devices like catheters and surgical guidewires. This was the first fully litigated merger case of the second Trump Administration and has particularly important implications regarding how this administration will "litigate the fix" in merger cases going forward.1

This note discusses both implications of FTC v. GTCR and some broader issues for parties that may be seeking to resolve agency concerns about a merger through a remedy.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from